ArticleBritish journal of cancer2020

Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment.

Linda K Rushworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.